A Four Week Trial of Hypertonic Saline in Children with Mild Cystic Fibrosis Lung Disease: Effect on Mucociliary Clearance and Clinical Outcomes

BACKGROUND: Hypertonic saline (HS) is commonly prescribed for children with cystic fibrosis (CF) despite the absence of strong data indicating clinical efficacy in a population with mild lung disease. We hypothesized that HS treatment would result in a sustained improvement in mucociliary clearance...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:J Cyst Fibros
Autors principals: Donaldson, Scott H., Samulski, T. Danielle, LaFave, Caroline, Zeman, Kirby, Wu, Jihong, Trimble, Aaron, Ceppe, Agathe, Bennett, William D., Davis, Stephanie D.
Format: Artigo
Idioma:Inglês
Publicat: 2020
Matèries:
Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC7736104/
https://ncbi.nlm.nih.gov/pubmed/32669217
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.jcf.2020.07.009
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars